Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 25, 2014 11:05 ET | Source: Chembio Diagnostics, Inc.

Chembio's HIV 1/2 STAT-PAK(R) Assay Receives CE Mark Approval for Rapid Point-of-Care Detection of HIV

MEDFORD, N.Y., March 25, 2014 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care ("POC") diagnostic tests for infectious diseases, announced today that its HIV 1/2...
March 25, 2014 10:26 ET | Source: CEL-SCI Corporation

CEL-SCI CEO Geert Kersten to Be Interviewed Live Today on Clear Channel Business Talk Radio

VIENNA, VA--(Marketwired - Mar 25, 2014) - CEL-SCI Corporation (NYSE MKT: CVM), a leading research and development company dedicated to improving the treatment of cancer and other diseases by...
March 25, 2014 08:44 ET | Source: Easton Pharmaceuticals, Inc.

Easton Pharmaceuticals Announces Update to Its Cancer Drug Initiative: Majority Acquisition, Patent Strategy and Clinical Development Along With New Partnership Proposal Involving Medicinal Marijuana Drug Development

TORONTO, ON--(Marketwired - Mar 25, 2014) - Easton Pharmaceuticals, Inc. (OTC: EAPH), a specialty pharmaceutical company that owns, designs, develops, and markets an array of topically-delivered...
March 25, 2014 08:30 ET | Source: BG Medicine, Inc.

Publication Reports Clinical Utility of BGM Galectin-3(R) Test for Prediction of Near-Term Rehospitalization in Patients With Heart Failure

WALTHAM, Mass., March 25, 2014 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD) announced today the publication of results, in the American Heart Journal, of an analysis of aggregated data from...
March 25, 2014 08:30 ET | Source: Integra LifeSciences Holdings Corporation

Integra LifeSciences Launches Integra(R) Wound Matrix (Thin)

PLAINSBORO, N.J., March 25, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the expansion of its skin and wound product line with the introduction of...
March 25, 2014 08:03 ET | Source: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceutical Partners Announces Recommendation of Data Monitoring Committee to Continue Pivotal Phase 3 Clinical Trial for Firdapse(TM)

CORAL GABLES, Fla., March 25, 2014 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX), a specialty pharmaceutical company focused on developing safe and effective approved...
March 25, 2014 08:00 ET | Source: Egalet Corporation

Egalet Initiates Bioequivalence Studies for Abuse-Deterrent Morphine Egalet-001

WAYNE, Penn., March 25, 2014 (GLOBE NEWSWIRE) -- Egalet Corporation (Nasdaq:EGLT) ("Egalet") today announced the initiation of the bioequivalence (BE) program for Egalet-001, an abuse-deterrent,...
March 25, 2014 07:00 ET | Source: Swedish Orphan Biovitrum AB

Cometriq® godkänt i Europa för behandling av progressiv, inoperabel lokalt framskriden eller metastaserande medullär sköldkörtelcancer

Swedish Orphan Biovitrum ABs (publ) (Sobi) partner Exelixis, Inc. (NASDAQ:EXEL) tillkännager idag att EU-kommissionen har godkänt Cometriq® (cabozantinib) för behandling av vuxna patienter med...
March 25, 2014 03:00 ET | Source: DBV Technologies S.A.

DBV annonce la présentation de données sur EPIT lors du prochain congrès de l'EAACI (Académie européenne d'allergie et d'immunologie clinique)

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} DBV annonce la présentation de données sur...
March 24, 2014 19:39 ET | Source: MedX Health Corp.

MedX Health Corp. Announces Extension of Private Placement

MISSISSAUGA, ONTARIO--(Marketwired - March 24, 2014) - MedX Health Corp. ("MedX" or the "Company") (TSX VENTURE:MDX) announces that it has extended, to April 11, 2014, the date for...
March 24, 2014 16:15 ET | Source: Chimerix, Inc.

Chimerix to Present a Summary of Brincidofovir's (CMX001) Hematologic Safety at the Annual Meeting of the European Group for Blood and Marrow Transplantation

DURHAM, N.C., March 24, 2014 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today announced an...
March 24, 2014 16:05 ET | Source: Celsus Therapeutics

Celsus Therapeutics Provides Year End 2013 Financial Results and Corporate Highlights

NEW YORK and LONDON, March 24, 2014 (GLOBE NEWSWIRE) -- Celsus Therapeutics Plc (Nasdaq:CLTX), an emerging growth, development-stage biotech company, today announced its financial results and provided...
March 24, 2014 09:00 ET | Source: General Atomics

FDA Grants Diazyme 510(k) Clearance to Market Its Vitamin D Assay for Clinical Chemistry Analyzers

SAN DIEGO, CA--(Marketwired - Mar 24, 2014) - Diazyme Laboratories today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to market its Vitamin D assay for...
March 24, 2014 08:30 ET | Source: AIM ImmunoTech Inc.

Hemispherx Biopharma, Inc. Presented Clinical Interpretations on CFS Treatment at the 11th Biennial International Research and Clinical Conference

PHILADELPHIA, March 24, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) participated in the 11th Biennial International Research and Clinical Conference held in San Francisco,...
March 24, 2014 08:00 ET | Source: Rockwell Medical, Inc.

Rockwell Medical Submits New Drug Application for Triferic(TM) for the Treatment of Iron Replacement in Chronic Kidney Disease Patients on Hemodialysis

WIXOM, Mich., March 24, 2014 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease...
March 24, 2014 08:00 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals Announces Supplemental Application for Site Transfer of Isradipine

NORTHVALE, N.J., March 24, 2014 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) today announced that on March 21, 2014, the Company filed a Changes Being...
March 24, 2014 03:00 ET | Source: GUERBET

Guerbet et Sirtex vont mener en collaboration des études cliniques sur le cancer du foie primitif et secondaire

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Communiqué de...
March 24, 2014 03:00 ET | Source: GUERBET

Guerbet and Sirtex to Collaborate on Clinical Studies in Primary and Secondary Liver Cancer

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Press Release ...
March 23, 2014 04:02 ET | Source: Medigus Ltd.

Medigus Receives FDA Clearance for Next Generation MUSE(TM) System

- New MUSE(TM) System Features Significant Technological Improvements, Including Enhanced User Interface and Software Control - - Company to Launch MUSE(TM) System At U.S. Centers of...
March 22, 2014 07:25 ET | Source: Brower Piven, A Professional Corporation

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Sarepta Therapeutics, Inc. to Contact Brower Piven Before the March 28, 2014 Lead Plaintiff Deadline (SRPT)

STEVENSON, Md., March 22, 2014 (GLOBE NEWSWIRE) -- Brower Piven, A Professional Corporation announces that a class action lawsuit has been commenced in the United States District Court for the...
March 21, 2014 20:43 ET | Source: Align Technology

Align Technology Provides Update Regarding Patent Case Against ClearCorrect

SAN JOSE, CA--(Marketwired - Mar 21, 2014) - Align Technology, Inc. (NASDAQ: ALGN) today announced that the International Trade Commission ("ITC") extended the target date for completion of its...
March 21, 2014 19:06 ET | Source: The Rosen Law Firm PA

ALERT: The Rosen Law Firm Reminds The Medicines Company Investors of Important April 22, 2014 Class Action Deadline-- MDCO

NEW YORK, March 21, 2014 (GLOBE NEWSWIRE) -- The Rosen Law Firm, P.A. reminds purchasers of the securities of The Medicines Company (Nasdaq:MDCO) between February 20, 2013 and February 12. 2014, of...
March 21, 2014 16:45 ET | Source: Galectin Therapeutics Inc.

Galectin Therapeutics Reports 2013 Financial Results

NORCROSS, Ga., March 21, 2014 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (Nasdaq:GALT), the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, today...
March 21, 2014 14:37 ET | Source: Novartis Pharma AG

Novartis announces US FDA approval of Xolair® for chronic idiopathic urticaria (CIU)

Xolair® (omalizumab) is the first and only licensed therapy in the US for the nearly 50% of patients with chronic idiopathic urticaria (CIU) who do not respond to approved doses of...
March 21, 2014 13:31 ET | Source: Lumenis

Lumenis Grows Its Flagship Laser Hair Removal Offering With the Introduction of LightSheer(R) INFINITY(TM) and LightSheer(R) DESIRE(TM)

YOKNEAM, ISRAEL--(Marketwired - Mar 21, 2014) - Lumenis Ltd. (NASDAQ: LMNS), the world's largest medical laser company for aesthetic, surgical and ophthalmic applications, announced today the...
March 21, 2014 08:13 ET | Source: Thérapeutique Knight Inc.

Thérapeutique Knight conclut une entente visant un placement privé par acquisition ferme de bons de souscription spéciaux de 75 millions de dollars

MONTRÉAL, QUÉBEC--(Marketwired - 21 mars 2014) - LE PRÉSENT COMMUNIQUÉ EST CENSÉ ÊTRE DIFFUSÉ AU CANADA UNIQUEMENT. IL NE DOIT PAS ÊTRE REMIS À UNE...
March 21, 2014 08:03 ET | Source: Knight Therapeutics Inc.

Knight Therapeutics Enters into Agreement for a $75 Million "Bought Deal" Private Placement of Special Warrants

MONTREAL, QUEBEC--(Marketwired - March 21, 2014) - THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR...
March 21, 2014 08:00 ET | Source: BioCorRx

BioCorRx, Inc. Announces Three New Additions to Advisory Board

Los Angeles, March 21, 2014 (GLOBE NEWSWIRE) -- BioCorRx, Inc. (OTCQB: BICX), a leader in addiction treatment and rehabilitation programs, announces three new additions to its advisory board. ...
March 21, 2014 06:00 ET | Source: Cellceutix

Cellceutix to Initiate Psoriasis Clinical Trial

BEVERLY, MA--(Marketwired - Mar 21, 2014) - Cellceutix Corporation (OTCQB: CTIX) (the "Company"), a clinical stage biopharmaceutical company developing innovative therapies in oncology,...
March 21, 2014 03:00 ET | Source: Xvivo Perfusion AB

FDA:s Expertpanelen röstade enhälligt för att XPS™ med STEEN Solution™ uppfyller kraven för HDE

Den av FDA inkallade expertpanelen röstade enhälligt, med röstsiffrorna 10-0, för att XPS™ System med STEEN Solution™ uppfyller kraven för HDE-godkännande (Humanitarian Device Exemption). XVIVO...
March 21, 2014 03:00 ET | Source: Xvivo Perfusion AB

The FDA Advisory Panel voted unanimously that XPS™ with STEEN Solution™ meets the requirements for HDE

The Advisory Panel convened by the FDA voted unanimously, by 10 votes to 0, that the XPS™ System with STEEN Solution™ meets the requirements for HDE (Humanitarian Device Exemption) approval. XVIVO...
March 21, 2014 02:00 ET | Source: Biotie Therapies

Biotie saa totsadenantin globaalit oikeudet UCB:lta

BIOTIE THERAPIES OYJ PÖRSSITIEDOTE 21.3.2014 klo 8.00 Biotie saa totsadenantin globaalit oikeudet UCB:lta * Totsadenantti on siirtymässä Faasi 3 kehitykseen Parkinsonin...
March 20, 2014 18:30 ET | Source: Levi & Korsinsky, LLP

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against GERON CORPORATION and Its Board of Directors and a Lead Plaintiff Deadline of May 13, 2014 -- GERN

NEW YORK, NY--(Marketwired - Mar 20, 2014) - Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Northern District of...
March 20, 2014 16:05 ET | Source: Melinta Therapeutics, Inc.

Cempra, Inc. to Present at The 21st Annual Future Leaders in the Biotech Industry Conference and Needham & Co. 12th Annual Healthcare Conference

CHAPEL HILL, N.C., March 20, 2014 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP) today announced that Prabhavathi Fernandes, Ph.D., chief executive officer of Cempra, will present at The 21st Annual...
March 20, 2014 16:01 ET | Source: Conatus Pharmaceuticals Inc.

Conatus Pharmaceuticals to Report Fourth Quarter and Full Year 2013 Financial Results

SAN DIEGO, March 20, 2014 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT), a biotechnology company focused on the development and commercialization of novel medicines to treat liver...
March 20, 2014 16:00 ET | Source: ClearPoint Neuro, Inc.

MRI Interventions Reports 2013 Financial Results

MEMPHIS, Tenn., March 20, 2014 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC), a commercial stage medical device company focused on creating innovative platforms for performing the next...
March 20, 2014 14:40 ET | Source: AB Science

AB Science: CHMP negative opinion on appeal for conditional authorization of Masitinib in second-line treatment of GIST

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Paris, 20 March 2014, 7:00 pm AB Science...
March 20, 2014 14:40 ET | Source: AB Science

AB Science : le CHMP a émis une opinion négative en appel pour l'autorisation conditionnelle du masitinib dans le traitement de deuxième ligne des tumeurs stromales gastro-intestinales (GIST)

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Paris, 20 Mars 2014, 19h AB Science annonce...
March 20, 2014 10:00 ET | Source: Medical Marijuana Inc

Medical Marijuana Inc. and LiveWire Ergogenics Inc. Sign Memorandum of Understanding to Develop HempWire, LLC

SAN DIEGO, March 20, 2014 (GLOBE NEWSWIRE) -- Medical Marijuana Inc. (OTC Pink:MJNA) is pleased to inform shareholders and the general public it has signed a memorandum of understanding (MOU) to...
March 20, 2014 09:37 ET | Source: EDAP TMS S.A.

EDAP Completes FDA Q&A Session for Its Ablatherm-HIFU Pre-Market Approval Application

LYON, France, March 20, 2014 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that it has completed its response to questions from the FDA...
March 20, 2014 09:00 ET | Source: LiveWire Ergogenics, Inc.

Medical Marijuana Inc. and LiveWire Ergogenics Inc. Sign Memorandum of Understanding to Develop HempWire, LLC

SAN DIEGO, CA--(Marketwired - Mar 20, 2014) - Medical Marijuana Inc. (PINKSHEETS: MJNA) is pleased to inform shareholders and the general public it has signed a memorandum of understanding (MOU) to...
March 20, 2014 09:00 ET | Source: Cortice Biosciences

Cortice Announces Enrollment of a Phase 2 Trial Evaluating TPI 287 Plus Avastin(R) for Treatment of Glioblastoma Previously Treated with Anti-Angiogenic Therapy

NEW YORK, March 20, 2014 (GLOBE NEWSWIRE) -- Cortice Biosciences announced today that enrollment has begun in the first stage of a Phase 2 open-label trial designed to evaluate the safety and efficacy...
March 20, 2014 09:00 ET | Source: CannaVest Corp.

CannaVest Corp. Continues to Lay Groundwork for Domestic U.S. Industrial Hemp Industry

SAN DIEGO, March 20, 2014 (GLOBE NEWSWIRE) -- CannaVest Corp. (OTCBB:CANV), a leading industrial hemp company, is continuing its plans to be in the forefront of establishing a domestic industrial hemp...
March 20, 2014 08:30 ET | Source: Cutera, Inc.

Cutera Introduces Two New Laser Systems

BRISBANE, Calif., March 20, 2014 (GLOBE NEWSWIRE) -- Cutera, Inc. (Nasdaq:CUTR), a leading provider of laser, light and other energy-based aesthetic systems for practitioners worldwide, is unveiling...
March 20, 2014 08:05 ET | Source: BioTelemetry, Inc.

BioTelemetry, Inc. Announces the Acquisition of the Cardiac Patient Services Business of Biomedical Systems, Corp.

MALVERN, Penn., March 20, 2014 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (Nasdaq:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of...
March 20, 2014 08:00 ET | Source: LENSAR, Inc.

LENSAR Closes Deal With Optegra to Install Its Refractive Cataract Laser System Across All of the Specialty Eye Group's U.K. Hospitals

ORLANDO, FL--(Marketwired - Mar 20, 2014) - LENSAR, Inc., today announced it closed a deal with Optegra to install the LENSAR™ Laser System for refractive cataract surgery across all of its...
March 20, 2014 08:00 ET | Source: Zynex, Inc.

Zynex Schedules Year End 2013 Earnings Conference Call and Webcast

LONE TREE, CO--(Marketwired - Mar 20, 2014) - Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain...
March 20, 2014 08:00 ET | Source: BG Medicine, Inc.

BG Medicine Announces Issuance of Patent Covering Galectin-3 Testing for Cardiac Resynchronization Therapy

WALTHAM, Mass., March 20, 2014 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD) today announced that on March 18, 2014, the United States Patent and Trademark Office issued patent 8,672,857, titled...
March 20, 2014 08:00 ET | Source: ABIOMED, Inc.

Abiomed Completes Patient Enrollment in RECOVER RIGHT Impella Study

DANVERS, Mass., March 20, 2014 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today announced the completion of the 30th patient...
March 20, 2014 07:50 ET | Source: BG Medicine, Inc.

BG Medicine Reports 2013 Fourth Quarter and Year End Financial Results

WALTHAM, Mass., March 20, 2014 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), the developer of the BGM Galectin-3® Test, today reported financial results for the three months ended and year...